New technology Vacuum Assisted Breast Biopsy (VABB) which will help to diagnose and treat scar-free breast cancer tumor is been introduced in a Bangalore hospital.
Introducing VABB the HealthCare Global Enterprises Ltd (HCG) has informed that the biopsy for small lesions can now be performed under the mammographic, stereo-tactic and ultrasound guidance.
“Precise guidance helps the doctor to site the abnormality more accurately and the procedure requires only a local anesthesia, reducing the whole procedure to a comfortable 45 minutes. The procedure involves a single needle insertion with vacuum pressure under the guidance of chosen imaging modality,” the statement said.
Without withdrawing and reinserting the needle, multiple samples can be collected with VABB, which are larger in size than a conventional needle biopsy procedure and larger samples eventually increase the accuracy of the diagnosis and better treatment protocols.
Dr Sudhakar, Breast imaging and Intervention Radiologist, informs, “As we have digital mammography and advanced ultrasound scan, small lesions are possible to be detected well before it actually presents. It was difficult to access to such small lesion through traditional core biopsy, the new biopsy system makes it easy to extract large volume of tissue, which also helps us diagnose hormone receptor and conduct Genomic studies. We can excise fibroadenomas in young age with symptoms or family history. This daycare procedure is safe, cost effective and scar-less”
These new technologies use very sensitive techniques and can pick up abnormalities as small as 3-5mm in the breast; however the issue in India was the unavailability of means of sampling these cases found at early stages of the diseases and then to understand their nature as cancerous or non-cancerous
As per IARC (WHO) breast cancer constituted 22.2 per cent of cancer in 2008 which increased to 27 per cent in 2012. Of the 300,000 cancer cases treated by oncologists in India, more than 10 per cent are breast cancers out of which one third are new cases.
With women generally presenting late for diagnosis, more than 60 per cent of patients present at the locally advanced stages of breast cancer and the mortality associated with it is as high as 35 per cent.